SAG therapy restores bone growth and reduces enchondroma incidence in a model of skeletal chondrodysplasias caused by Ihh deficiency is a research paper published in Molecular Therapy β Methods & Clinical Development (2021). On theSindex it has a DataRank of 0.422. It has been cited 8 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0922
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) β log1p(Cq) divided by its reference count β out of 6 citers.
NIA
Grant: AG048388
National Natural Science Foundation of China
Grant: 82102608
China Scholarship Council
Grant: 201706260178
NIDCR
Grant: DE023105
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: AR066101
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: P30 AR069619
NIDCR NIH HHS
Grant: R01 DE023105
NIAMS NIH HHS
Grant: R01 AR066101
NIA NIH HHS
Grant: R01 AG048388
National Institutes of Health
Grant: 5R01DE023105-05
Regulation of skeletal development and homeostasis by IFT protein
National Institutes of Health
Grant: 7R01AG048388-03
Function of Regulator of G protein signaling in aging skeleton
National Institutes of Health
Grant: 7R01AR066101-03
Role of RGS12, a Regulator of G protein Signaling, in Bone Remodeling
National Institutes of Health
Grant: 1P30AR069619-01
Overall: Resource-based Center for Musculoskeletal Disorders Research
National Institutes of Health
Penn Center for Musculoskeletal Disorders
Fields of Study
Keywords
Sustainable Development Goals